BACTERICIDAL ANTIBODY RECOGNITION OF A PORA EPITOPE OF NEISSERIA-MENINGITIDIS - CRYSTAL-STRUCTURE OF A FAB FRAGMENT IN COMPLEX WITH A FLUORESCEIN-CONJUGATED PEPTIDE

Citation
Jmh. Vandenelsen et al., BACTERICIDAL ANTIBODY RECOGNITION OF A PORA EPITOPE OF NEISSERIA-MENINGITIDIS - CRYSTAL-STRUCTURE OF A FAB FRAGMENT IN COMPLEX WITH A FLUORESCEIN-CONJUGATED PEPTIDE, Proteins, 29(1), 1997, pp. 113-125
Citations number
52
Categorie Soggetti
Biology
Journal title
ISSN journal
08873585
Volume
29
Issue
1
Year of publication
1997
Pages
113 - 125
Database
ISI
SICI code
0887-3585(1997)29:1<113:BAROAP>2.0.ZU;2-X
Abstract
Class 1 outer membrane protein PorA of Neisseria meningitidis is a vac cine candidate against bacterial meningitis, Antibodies against PorA a re able to induce complement-mediated bacterial killing and thereby pl ay an important role in protection against meningococcal disease, Bact ericidal antibodies are all directed against variable regions VR1 and VR2 of the PorA sequence, corresponding to loops 1 and 4 of a two-dime nsional topology model of the porin with eight extracellular loops, We have determined the crystal structure to 2.6 Angstrom resolution of t he Fab fragment of bactericidal antibody MN12H2 against meningococcal PorA in complex with a linear fluorescein-conjugated peptide TKDTNNNL derived from the VR2 sequence of sero-subtype P1.7,16 (residues 180-18 7) from meningococcal strain H44/76, The peptide folds deeply into the binding cavity of the Fab molecule in a type I beta-turn, with the mi nimal P1.16 epitope DTNNN virtually completely buried, The structure r eveals II-bonds and van der Waals interactions with all minimal epitop e residues and one essential salt bridge between Asp-182 of the peptid e and His-31 of the MN12H2 light chain, The key components of the reco gnition of PorA epitope P1.16 by bactericidal antibody MN12H2 correspo nd well with available thermodynamic data from binding studies, Furthe rmore, they indicate the structural basis of an increased endemic inci dence of infection by group B meningococci in England and Wales since 1981 associated with the occurrence of an Neisseria meningitidis escap e mutant (strain MC58), The observed three-dimensional conformation of the peptide provides a rationale for the development of a synthetic p eptide vaccine against meningococcal disease. (C) 1997 Wiley-Liss, Inc .